PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study

Phospholipid transferprotein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Although many studies have investigated the role of PLTP in atherogenesis, the role of PLTP in atherosclerotic diseases is unclear. We investigated the association of serum PL...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Axel Schlitt, Stefan Blankenberg, Christoph Bickel, Karl J. Lackner, Gunnar H. Heine, Michael Buerke, Karl Werdan, Lars Maegdefessel, Uwe Raaz, Hans J. Rupprecht, Thomas Munzel, Xian-Cheng Jiang
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2009-04-01
Rangatū:	Journal of Lipid Research
Ngā marau:	lipid transfer proteins atherosclerosis 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S0022227520308701
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

PLTP activity is a risk factor for subsequent cardiovascular events in CAD patients under statin therapy: the AtheroGene Study

Ngā tūemi rite